SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-067404
Filing Date
2017-11-09
Accepted
2017-11-09 16:26:31
Documents
2
Period of Report
2017-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-26160_28k.htm 8-K 27973
2 EX-5.1 a17-26160_2ex5d1.htm EX-5.1 11362
  Complete submission text file 0001104659-17-067404.txt   40646
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 171191226
SIC: 2835 In Vitro & In Vivo Diagnostic Substances